Skip to main content

Peer Review reports

From: Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg®) in children with relapsed/refractory myeloid leukemia

Original Submission
14 Feb 2006 Submitted Original manuscript
1 May 2006 Reviewed Reviewer Report - Frederick Appelbaum
6 Jun 2006 Author responded Author comments - Benoit Brethon
Resubmission - Version 2
6 Jun 2006 Submitted Manuscript version 2
13 Jun 2006 Author responded Author comments - Benoit Brethon
Resubmission - Version 3
13 Jun 2006 Submitted Manuscript version 3
16 Jun 2006 Author responded Author comments - Benoit Brethon
Resubmission - Version 4
16 Jun 2006 Submitted Manuscript version 4
Publishing
28 Jun 2006 Editorially accepted
28 Jun 2006 Article published 10.1186/1471-2407-6-172

You can find further information about peer review here.

Back to article page